Remus Pharmaceuticals Limited (NSE:REMUS)
699.80
+41.80 (6.35%)
Apr 29, 2026, 3:29 PM IST
-30.89% (1Y)
| Market Cap | 7.67B |
| Revenue (ttm) | 7.48B |
| Net Income (ttm) | 335.10M |
| Shares Out | 11.66M |
| EPS (ttm) | 27.37 |
| PE Ratio | 24.04 |
| Forward PE | n/a |
| Dividend | 1.00 (0.15%) |
| Ex-Dividend Date | Nov 14, 2025 |
| Volume | 17,000 |
| Average Volume | 5,465 |
| Open | 658.00 |
| Previous Close | 658.00 |
| Day's Range | 658.00 - 710.00 |
| 52-Week Range | 580.00 - 1,139.50 |
| Beta | 0.22 |
| RSI | 63.04 |
| Earnings Date | May 15, 2026 |